Cardio Diagnostics
Business Services · Illinois, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
311 W Superior St Ste 444, Chicago, Illi...Phone Number
(302) 281-2147Website
www.cdio.aiRevenue
<$5 MillionStock Symbol
CDIOIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cardio Diagnostics
Cardio Diagnostics is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. With prevention and early detection as the new norm, epigenetics-based technologies driven by artificial intelligence will usher in an era of Precision Cardiovascular Medicine. The company's flagship solutions were developed in partnership with dedicated scientists and clinicians; the Cardio Diagnostics' Epi+Gen CHD test helps clinicians better assess each patient's unique risk profile for disease.Explore more
Cardio Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cardio Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Cardio Diagnostics has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Cardio Diagnostics
Check out if Cardio Diagnostics is spiking on competitors!
Cardio Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Cardio Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Cardio Diagnostics had a recent Job posting/layoffs
Earning: See what the market has to say on Cardio Diagnostics recently announced quarterly report
Product Launch: Get notified when Cardio Diagnostics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Cardio Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cardio Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cardio Diagnostics.
Cardio Diagnostics financials insights
Gather financial insights about Cardio Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Debt
$11.4M
Cardio Diagnostics Tech Stack
A closer look at the technologies used by Cardio Diagnostics
Most Recent Scoops
Event
Product Marketing, Events, Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology
Event
Product Marketing, Events, Research & Development, Business Development, Logistics / Supply Chain, Bioengineering, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Manufacturing Operations
Funding
Cardio Diagnostics has been authorized to issue up to 50 million shares of its common stock and/or securities convertible into or exercisable for common stock, with a maximum aggregate dollar amount not to exceed $10 million, in one or more non-public transactions within three months of the 2024 annual meeting, subject to NASDAQ approval for potential extension up to six months.
Share Placement, Business Finance, Corporate Strategy, Finance
Earnings
Business Insurance, Operations
Earnings
Laboratory Operations, Operations
Cardio Diagnostics News & Media
IBN Initiates Coverage of Cardio Diagnostics Holdings Inc.
AUSTIN, Texas, April 08, 2026 (GLOBE NEWSWIRE) -- via IBN -- Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), a precision cardiovascular medicine company leveraging epigenetics, genetics, and artificial intelligence for the prevention and detection of cardiovascular disease, has engaged IBN, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy.Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced an agreement with AGEPHA Pharma.Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics announced that the Japan Patent Office has issued a patent for another set of biomarkers in the company’s IP portfolio.Cardio Diagnostics Holdings, Inc. (CDIO): A Bull Case Theory
We came across a bullish thesis on Cardio Diagnostics Holdings, Inc.(CDIO) on Stock Pursuit’s Substack. In this article, we will summarize the bulls’ thesis on CDIO. Cardio Diagnostics Holdings, Inc. (CDIO)’s share was trading at $4.4 as of 3rd June according to Yahoo Finance. Cardio Diagnostics (CDIO), currently trading below net cash with no long-term debt and […]
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Cardio Diagnostics
Sign Up For FreeTo access detailed company insights
Cardio Diagnostics is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. With prevention and early detection as the new norm, epigenetics-based technologies driven... Read More
